arginyl-glycyl-aspartyl-serine has been researched along with Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Itoh, I; Kojima, M; Komazawa, H; Nishi, N; Nishikawa, N; Ono, M; Saiki, I; Tokura, S; Yoneda, J; Yoo, YC | 1 |
1 other study(ies) available for arginyl-glycyl-aspartyl-serine and Lymphoma
Article | Year |
---|---|
Inhibition of tumor metastasis by Arg-Gly-Asp-Ser (RGDS) peptide conjugated with sulfated chitin derivative, SCM-chitin-RGDS.
Topics: Amino Acid Sequence; Animals; Cell Adhesion; Chitin; Liver Neoplasms; Lung Neoplasms; Lymphoma; Melanoma, Experimental; Mice; Molecular Sequence Data; Neoplasm Metastasis; Neoplasms, Experimental; Oligopeptides | 1993 |